Market Overview The global Immuno Oncology (IO) market is poised for significant growth, projected to reach a valuation of $129.18 billion by 2032, expanding at a robust CAGR of 20.0% during the forecast period. This exponential growth is primarily driven by the increasing prevalence of various cancers worldwide, growing awareness of immunotherapy solutions, and the rising adoption of...